Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

An Exploratory Study of the Role of 18F-FSPG PET/CT Imaging for Cancer Patients Receiving Therapy

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT02599194
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:37:03.265668+00:00
Published At
2019-01-03T00:00:00+00:00
Record Updated At
2019-01-03
Results Posted At
2019-01-03
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["B-Cell Neoplasm", "Estrogen Receptor Negative", "HER2/Neu Negative", "Metastatic Renal Cell Cancer", "Progesterone Receptor Negative", "Stage III Mesothelioma", "Stage III Renal Cell Cancer", "Stage IIIA Breast Cancer", "Stage IIIA Non-Small Cell Lung Cancer", "Stage IIIB Non-Small Cell Lung Cancer", "Stage IIIC Breast Cancer", "Stage IV Breast Cancer", "Stage IV Mesothelioma", "Stage IV Non-Small Cell Lung Cancer", "Stage IV Renal Cell Cancer", "Triple-Negative Breast Carcinoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2019-01-03"
protocolSection.identificationModule.nctId
"NCT02599194"
protocolSection.identificationModule.officialTitle
"An Exploratory Study of the Role of 18F-FSPG PET/CT Imaging for Cancer Patients Receiving Therapy"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2019-01-03"

Study condition terms

  • B-Cell Neoplasm (protocolSection.conditionsModule.conditions)
  • Estrogen Receptor Negative (protocolSection.conditionsModule.conditions)
  • HER2/Neu Negative (protocolSection.conditionsModule.conditions)
  • Metastatic Renal Cell Cancer (protocolSection.conditionsModule.conditions)
  • Progesterone Receptor Negative (protocolSection.conditionsModule.conditions)
  • Stage III Mesothelioma (protocolSection.conditionsModule.conditions)
  • Stage III Renal Cell Cancer (protocolSection.conditionsModule.conditions)
  • Stage IIIA Breast Cancer (protocolSection.conditionsModule.conditions)
  • Stage IIIA Non-Small Cell Lung Cancer (protocolSection.conditionsModule.conditions)
  • Stage IIIB Non-Small Cell Lung Cancer (protocolSection.conditionsModule.conditions)
  • Stage IIIC Breast Cancer (protocolSection.conditionsModule.conditions)
  • Stage IV Breast Cancer (protocolSection.conditionsModule.conditions)
  • Stage IV Mesothelioma (protocolSection.conditionsModule.conditions)
  • Stage IV Non-Small Cell Lung Cancer (protocolSection.conditionsModule.conditions)
  • Stage IV Renal Cell Cancer (protocolSection.conditionsModule.conditions)
  • Triple-Negative Breast Carcinoma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.